Clinical Trial Update: A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluates amivantamab as a standalone therapy and in combination with standard-of-care chemotherapy for advanced or metastatic colorectal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Amivantamab (amivantamab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Advanced or Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: RECRUITING